Register of Blood Stem Cell Transplantation

NCT04263857 · tracked via the Priya Life Science Germany tracker

Sponsor

Technical University of Munich

Phase

Observational

Started

2017-11-01

Last updated

2023-11-24

Condition(s) studied

Hematologic Malignancies

Study summary

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * signed IC * patients eligible for stem cell transplantation Exclusion Criteria: * unable to consent to study participation

Primary outcome measure(s)

Register of stem cell transplantation — approximately over 20 years
Recording of all stem cell transplantations over many years

Trial sites (1)

Facility	City	Region	Status
Klinikum rechts der Isar der TU München	Munich	Germany	Recruiting

More Technical University of Munich trials in Germany

Blood Flow Restriction Training For The Treatment Of Lateral Epicondylopathy Recruiting

Prehabilitation in Childhood Soft Tissue or Bone Sarcomas Active, not recruiting

LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL) Recruiting

Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy Recruiting

Covid-19 Predictors: Safety of Gynecological Oncology Patients Undergoing Systemic Cancer Therapy Active, not recruiting

Other trials for the same condition

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies Active, not recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04263857 on ClinicalTrials.gov ↗ ← All trials in Germany